miR-375 was also upregulated in estrogen receptor alpha- (ERα-) positive breast cancer cell lines, which promoted cell proliferation and induced ERα upregulation via RASD1, a negative regulator of ERα [15]. Here, RASD1 is linked to breast carcinoma.